Acute Kidney Injury News

A risk score based on 8 years of data showed excellent prediction of risk for contrast-induced acute kidney injury in patients undergoing PCI, researchers reported at the American Heart Association Scientific Sessions.

Patients with chronic kidney disease are not at an increased risk for AKI or death after chimeric antigen receptor T-cell therapy, according to a speaker at ASN Kidney Week.

By the age of 15 years, one-third of patients in a study from the Netherlands experienced one or more signs of kidney injury, leading researchers to believe the cause of solitary functioning kidney may impact the risk of kidney injury.

Lower baseline eGFR, use of proton pump inhibitors and extrarenal immune-related adverse events are independent risk factors for AKI in patients treated with immune checkpoint inhibitors, according to data presented at ASN Kidney Week.

Hospital admission with an AKI diagnosis increases the risk for death, hospitalization, heart failure, pneumonia and sepsis after hospital discharge, according to results presented at ASN Kidney Week.

Patients who took proton pump inhibitors (PPIs) before cardiac surgery may be at an elevated risk for developing AKI, according to data presented at ASN Kidney Week.

Panelists opened 2021 ASN Kidney Week by discussing the impact that the COVID-19 virus can have on chronic kidney disease, in addition to how vaccinating vulnerable populations is the best way to end the pandemic.

Researchers in China found the risk for hospital-acquired AKI increased with higher levels of ambient nitrogen dioxide, according to a retrospective cohort study in Clinical Kidney Journal.

A speaker at the American Nephrology Nurses Association’s Nephrology Nursing Practice, Management & Leadership Conference discussed the development of AKI in patients who have hepatorenal syndrome or who use acetaminophen therapies.

In 2017, CMS changed the script for caring for patients diagnosed with AKI.